April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Overexpression of the POU Domain Transcription Factor Brn3b Causes Neurite Outgrowth in Cultured PC 12 Cells Under Condition of Oxygen Glucose Deprivation
Author Affiliations & Notes
  • Nitasha R Phatak
    Cell Biology and Immunology, Univ of North Texas Hlth Sci Ctr, Fort Worth, TX
    North Texas Eye Research Instutute, Fort Worth, TX
  • Dorota L Stankowska
    Cell Biology and Immunology, Univ of North Texas Hlth Sci Ctr, Fort Worth, TX
    North Texas Eye Research Instutute, Fort Worth, TX
  • Raghu R Krishnamoorthy
    Cell Biology and Immunology, Univ of North Texas Hlth Sci Ctr, Fort Worth, TX
    North Texas Eye Research Instutute, Fort Worth, TX
  • Footnotes
    Commercial Relationships Nitasha Phatak, None; Dorota Stankowska, None; Raghu Krishnamoorthy, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1915. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nitasha R Phatak, Dorota L Stankowska, Raghu R Krishnamoorthy; Overexpression of the POU Domain Transcription Factor Brn3b Causes Neurite Outgrowth in Cultured PC 12 Cells Under Condition of Oxygen Glucose Deprivation. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1915.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Brn3b is a POU domain transcription factor shown to play a key role in regulating retinal ganglion cell axon outgrowth during development. Hypoxia is a contributing factor in many neurodegenerative diseases including glaucoma. The purpose of this study was to determine if overexpression of Brn3b could promote neurite outgrowth in cultured PC 12 cells during conditions of oxygen glucose deprivation (OGD).

Methods: Rat Pheochromocytoma cells (PC12) were grown on poly-D-lysine coated 100 mm dishes and transfected either with pCMV6-Brn3b (an expression vector encoding Brn3b) or pCMV6-Empty (empty vector). After 6 h of transfection, cells were maintained overnight in a differentiating medium containing NGF (100ng/ml). Then, the cells were transferred to glucose free DMEM and maintained for 2 h in 0.5% O2 and 5% CO2 (for hypoxia) in an Invivo2 200 hypoxia chamber. For the normoxia controls, PC12 cells overexpressing Brn3b or Empty vector were maintained in differentiating medium for 2 h in 5% CO2 and 95% air in a standard incubator. Protein extracts were isolated from these cells and analyzed for Brn3b and GAP43, TUBA-1 protein expression by immunoblot analysis. In another set of experiments, PC 12 cells were seeded on Poly-D-Lysine coated 25mm cover slips and transfected with either pCMV6-Brn3b or pCMV6 -Empty and maintained in differentiating medium for 4 days. The cells were subjected to either hypoxia (2h) or normoxia. Brn3b, GAP43 and TUBA-1 expression were analyzed using immunocytochemistry. Morphological changes in PC 12 cells transfected with Brn3b were studied by using confocal microscopy.

Results: Immunoblot analysis confirmed overexpression of Brn3b in PC12 cells transfected with Brn3b cDNA in normoxic as well as in OGD conditions. Interestingly, a marked upregulation of GAP-43 and ac-TUBA expression was observed in Brn3b overexpressing cells under conditions of normoxia and OGD. Overexpression of Brn3b in PC12 cells produced a statistically significant increase in maximum neurite length and number of neurites per cell under both conditions. A marked increase in immunostaining for Brn3b and neurite-specific GAP43, TUBA-1 were also observed in PC12 cells overexpressing Brn3b in condition of normoxia and OGD.

Conclusions: The transcription factor Brn3b could promote neurite outgrowth in PC12 cells under conditions of normoxia and OGD.

Keywords: 739 transcription factors • 533 gene/expression • 548 hypoxia  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×